An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label protocol designed to provide continued access to maraviroc to only
those subjects who have completed previous studies of maraviroc and continue to receive
clinical benefit.